查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1756492

综合多重诊断市场（按类型、最终用途、国家和地区）－2024 年至 2032 年产业分析、市场规模、市场占有率及预测

Syndromic Multiplex Diagnostics Market, By Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 357 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年综合多重诊断市场规模价值为 28.8976 亿美元，2024 年至 2032 年的复合年增长率为 4.2%。

症候群多重诊断市场-市场动态

对快速准确诊断的需求不断增长

对快速精准疾病识别日益增长的需求是综合多重诊断市场的关键驱动力。传统诊断方法通常耗时耗力，每次只能检测一种病原体。相较之下，综合诊断试剂盒的周转时间较短，并且能够从单一样本中同时检测多种病原体。这在传染病疫情管理以及重症监护中尤其重要，因为及时诊断可以显着影响患者的预后。全球对公共卫生防范和抗菌药物管理的日益关注，进一步刺激了对此类先进诊断技术的需求。

综合多重诊断市场－关键见解

根据我们的研究分析师，全球综合多重诊断市场预计在 2024 年至 2032 年期间的复合年增长率约为 4.2%。

按 2024 年类型细分，呼吸类别占据了市场主导地位。

根据最终用途，医院部门在 2024 年创造了最多的收入。

按地区划分，2024年北美是收入最高的地区。

综合多重诊断市场-細項分析：

全球综合症多重诊断市场分为三类：类型、最终用户和地区。

综合征多重诊断市场按类型细分为呼吸系统、胃肠道、中枢神经系统 (CNS) 和其他类型的综合征，其中包括复杂性泌尿道感染 (cUTI) 和性传染病 (STD)。其中，呼吸系统疾病占据了市场的主导地位。这种主导地位主要是由于呼吸道感染的高发生率，尤其是在季节性流感爆发和 COVID-19 等大流行期间。从单一样本中快速识别多种呼吸道病原体的需求可提高临床效率并支持有效的感染控制措施。此外，人们对早期诊断的认识不断提高，医院和护理点越来越多地采用综合征检测组，这继续增强了对呼吸道多重诊断解决方案的需求。

根据最终用途，综合征多重诊断市场细分为医院、诊断实验室和其他机构，包括诊所、研究机构和即时诊断机构。其中，医院占据主导地位，因为其患者数量众多、护理需求紧急且更容易获得先进的诊断技术。医院通常处理需要快速全面检测的复杂病例，而综合征检测组可以有效率地提供这些检测。在急诊和重症监护室整合多重诊断技术，可以及时做出决策并更好地管理患者，尤其是在传染病爆发期间。此外，医院还受益于内部实验室和训练有素的人员，这进一步支持了这些技术在关键综合征检测应用中的广泛应用。

综合多重诊断市场—地理洞察

从地理分布来看，综合征多重诊断市场分布于北美、亚太、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美在综合征多重诊断市场占据主导地位，这主要得益于其先进的医疗基础设施、强大的研发能力以及对创新诊断技术的早期应用。尤其是美国，在分子诊断和旨在改善早期疾病检测的公共卫生计划方面投入巨资，引领该地区的发展。公众对传染病的普遍认识、政府资金投入以及完善的报销框架进一步支撑了市场的成长。此外，呼吸道感染和慢性病的高发生率，以及强大的医院和诊断实验室网络，巩固了北美在全球综合征多重诊断领域的领先地位。

欧洲是综合征多重诊断市场的另一个领先地区，这得益于对高效诊断解决方案日益增长的需求以及对先进医疗技术的有力监管支持。德国、英国和法国等国家处于领先地位，受益于现代化的医疗保健体系和大量的公共卫生投资。该地区对抗菌药物管理和感染控制的重视加速了多重检测在临床环境中的应用。此外，老龄人口的增长以及呼吸道和胃肠道感染发病率的上升也进一步刺激了需求。欧洲致力于医疗保健创新，使其成为该市场的关键参与者。

综合多重诊断市场-竞争格局：

综合多重诊断市场由老牌诊断巨头和创新新进入者共同塑造。雅培实验室、赛默飞世尔科技、罗氏製药、凯杰和生物梅里埃等领导企业凭藉全面的多重检测组合和先进的分子平台占据主导地位。这些公司在研发方面投入巨资，旨在提高检测准确性、缩短週转时间并扩大病原体覆盖范围。新进业者则专注于开发快速的即时诊断解决方案，以占领利基市场。策略合作、併购进一步巩固了市场地位。这种竞争环境推动持续创新，提升诊断能力，并为全球患者提供及时有效的医疗服务。

最新动态：

2025 年 3 月，雅培推出了新的快速多重呼吸道检测面板，可在 30 分钟内提供结果，从而增强临床环境中的早期诊断和治疗。

2024 年 1 月，赛默飞世尔科技收购了一家专门从事自动化 PCR 技术的分子诊断公司，扩大了其综合征检测产品组合，从而扩大了其市场范围。

目录

第一章：综合多重诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 综合多重诊断市场片段（按类型）
    • 综合多重诊断市场片段（依最终用途）
    • 综合多重诊断市场（按国家/地区）
    • 综合多重诊断市场（按地区）
  • 竞争洞察

第三章：症候群多重诊断关键市场趋势

  • 综合多重诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 综合多重诊断市场限制
    • 市场限制的影响分析
  • 综合多重诊断市场机会
  • 症候群多重诊断市场未来趋势

第四章：综合多重诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：综合多重诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：综合多重诊断市场格局

  • 2023年综合多重诊断市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：综合多重诊断市场－依类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 呼吸系统
    • 胃肠道
    • 中枢神经系统
    • 其他类型的综合征（cUTI 和 STD）

第 8 章：综合多重诊断市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 诊断实验室
    • 其他的

第九章：综合多重诊断市场－按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美综合多重诊断主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测，按最终用途
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲综合多重诊断主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测，按最终用途
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区综合多重诊断主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（按类型）
    • 亚太市场规模及预测（依最终用途）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲综合多重诊断主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲综合多重诊断主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模和预测（按类型）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 10 章：关键供应商分析-综合多重诊断产业

  • 竞争仪錶板
  • 公司简介
    • Abbott Laboratories
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd
    • Qiagen
    • bioMerieux
    • DiaSorin SpA (Luminex Corporation)
    • Hologic, Inc.
    • Becton, Dickinson and Company (BD)
    • Applied BioCode
    • QIAGEN
    • Curetis GmbH
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5248

REPORT HIGHLIGHT

Syndromic Multiplex Diagnostics Market size was valued at USD 2,889.76 Million in 2024, expanding at a CAGR of 4.2% from 2024 to 2032.

Syndromic multiplex diagnostics is an advanced diagnostic approach that simultaneously tests for multiple pathogens or biomarkers associated with a specific syndrome using a single test panel. This method integrates molecular techniques, such as PCR, to rapidly identify the causative agents of illnesses with overlapping symptoms like respiratory, gastrointestinal, or neurological infections. By targeting a broad spectrum of pathogens in one test, it enhances diagnostic accuracy, reduces time to treatment, and supports more effective clinical decision-making. This approach is particularly useful in settings where rapid identification of the illness source is critical, such as hospitals, emergency care, and outbreak scenarios.

Syndromic Multiplex Diagnostics Market- Market Dynamics

Rising Demand for Rapid and Accurate Diagnostics

The growing need for fast and precise disease identification is a key driver for the syndromic multiplex diagnostics market. Traditional diagnostic methods are often time-consuming and limited to detecting one pathogen at a time. In contrast, syndromic panels offer quicker turnaround times and the ability to detect multiple pathogens simultaneously from a single sample. This is especially valuable in managing infectious disease outbreaks and in critical care settings, where timely diagnosis can significantly impact patient outcomes. Increased global focus on public health preparedness and antimicrobial stewardship further fuels the demand for such advanced diagnostics.

Syndromic Multiplex Diagnostics Market- Key Insights

According to our research analyst, the global Syndromic Multiplex Diagnostics Market is expected to develop at a CAGR of approximately 4.2% between 2024-2032.

Segmented by Type in 2024, the Respiratory category dominated the market.

Based on End Use, the Hospitals segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Syndromic Multiplex Diagnostics Market- Segmentation Analysis:

The global Syndromic Multiplex Diagnostics Market is divided into Three categories: Type, End-user, and Region.

The syndromic multiplex diagnostics market is segmented by type into Respiratory, Gastrointestinal, Central Nervous System (CNS), and Other Types of Syndromes, which include complicated urinary tract infections (cUTIs) and sexually transmitted diseases (STDs). Among these, the Respiratory segment holds the dominant share of the market. This dominance is primarily driven by the high prevalence of respiratory infections, especially during seasonal flu outbreaks and pandemics such as COVID-19. The need for rapid identification of multiple respiratory pathogens from a single sample enhances clinical efficiency and supports effective infection control measures. Moreover, growing awareness of early diagnosis and increasing adoption of syndromic panels in hospitals and point-of-care settings continue to bolster the demand for respiratory multiplex diagnostic solutions.

By end use, the syndromic multiplex diagnostics market is segmented into Hospitals, Diagnostic Laboratories, and Others, which include clinics, research institutes, and point-of-care settings. Among these, Hospitals represent the dominant segment due to their high patient volume, urgent care requirements, and greater access to advanced diagnostic technologies. Hospitals often deal with complex cases requiring rapid and comprehensive testing, which syndromic panels efficiently provide. The integration of multiplex diagnostics in emergency departments and intensive care units enables timely decision-making and better patient management, especially during infectious disease outbreaks. Additionally, hospitals benefit from in-house laboratories and trained personnel, further supporting the widespread adoption of these technologies for critical syndromic testing applications.

Syndromic Multiplex Diagnostics Market- Geographical Insights

Geographically, the Syndromic Multiplex Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the syndromic multiplex diagnostics market, primarily due to its advanced healthcare infrastructure, strong R&D capabilities, and early adoption of innovative diagnostic technologies. The United States, in particular, leads the region with significant investments in molecular diagnostics and public health initiatives aimed at improving early disease detection. Widespread awareness of infectious diseases, government funding, and well-established reimbursement frameworks further support market growth. Additionally, the high prevalence of respiratory infections and chronic conditions, along with a robust network of hospitals and diagnostic laboratories, reinforces North America's leading role in the global syndromic multiplex diagnostics landscape.

Europe is another leading region in the syndromic multiplex diagnostics market, driven by increasing demand for efficient diagnostic solutions and strong regulatory support for advanced medical technologies. Countries such as Germany, the United Kingdom, and France are at the forefront, benefiting from modern healthcare systems and substantial public health investments. The region's focus on antimicrobial stewardship and infection control has accelerated the adoption of multiplex panels in clinical settings. Moreover, the growing elderly population and rising incidence of respiratory and gastrointestinal infections have further contributed to demand. Europe's commitment to healthcare innovation positions it as a key player in this market.

Syndromic Multiplex Diagnostics Market- Competitive Landscape:

The syndromic multiplex diagnostics market is shaped by established diagnostics giants and innovative newcomers. Leading players such as Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche, Qiagen, and bioMerieux dominate with comprehensive multiplex panels and advanced molecular platforms. These companies invest heavily in R&D to enhance test accuracy, reduce turnaround times, and expand pathogen coverage. New entrants focus on developing rapid, point-of-care solutions to capture niche markets. Strategic collaborations, mergers, and acquisitions further strengthen market positions. This competitive environment drives continuous innovation, improving diagnostic capabilities and supporting timely, effective patient care worldwide.

Recent Developments:

In March 2025, Abbott launched a new rapid multiplex respiratory panel that delivers results in under 30 minutes, enhancing early diagnosis and treatment in clinical settings.

In January 2024, Thermo Fisher expanded its syndromic testing portfolio by acquiring a molecular diagnostics company specializing in automated PCR technologies, boosting its market reach.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Qiagen
  • Biomerieux
  • Diasorin S.P.A (Luminex Corporation)
  • Hologic, Inc.
  • Becton, Dickinson And Company (Bd)
  • Applied Biocode
  • Qiagen
  • Curetis Gmbh
  • Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • Other Types Of Syndromes (Cuti And Stds)

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Others

GLOBAL SYNDROMIC MULTIPLEX DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Syndromic Multiplex Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Syndromic Multiplex Diagnostics Market Snippet by Type
    • 2.1.2. Syndromic Multiplex Diagnostics Market Snippet by End Use
    • 2.1.3. Syndromic Multiplex Diagnostics Market Snippet by Country
    • 2.1.4. Syndromic Multiplex Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Syndromic Multiplex Diagnostics Key Market Trends

  • 3.1. Syndromic Multiplex Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Syndromic Multiplex Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Syndromic Multiplex Diagnostics Market Opportunities
  • 3.4. Syndromic Multiplex Diagnostics Market Future Trends

4. Syndromic Multiplex Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Syndromic Multiplex Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Syndromic Multiplex Diagnostics Market Landscape

  • 6.1. Syndromic Multiplex Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Syndromic Multiplex Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Respiratory
    • 7.1.3. Gastrointestinal
    • 7.1.4. Central Nervous System
    • 7.1.5. Other Types of Syndromes (cUTI and STDs)

8. Syndromic Multiplex Diagnostics Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Diagnostic Laboratories
    • 8.1.4. Others

9. Syndromic Multiplex Diagnostics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Syndromic Multiplex Diagnostics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Syndromic Multiplex Diagnostics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Syndromic Multiplex Diagnostics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Syndromic Multiplex Diagnostics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Syndromic Multiplex Diagnostics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Syndromic Multiplex Diagnostics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
    • 10.2.2. Thermo Fisher Scientific, Inc.
    • 10.2.3. F. Hoffmann-La Roche Ltd
    • 10.2.4. Qiagen
    • 10.2.5. bioMerieux
    • 10.2.6. DiaSorin S.p.A (Luminex Corporation)
    • 10.2.7. Hologic, Inc.
    • 10.2.8. Becton, Dickinson and Company (BD)
    • 10.2.9. Applied BioCode
    • 10.2.10. QIAGEN
    • 10.2.11. Curetis GmbH
    • 10.2.12. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us